National and Kapodistrian University of Athens
Μηχανισμοί αλληλεπίδρασης του β αδρενεργικού συστήματος με το σύστημα της θυρεοειδικής ορμόνης-θυρεοειδικών υποδοχέων σε μοντέλο απομονωθέντων νεογνικών καρδιομυοκυττάρων
Abstract
dc:descriptionPharmacologic treatments which aim to induce physiological hypertrophy are now thought as novel treatments for heart failure. Thus, clenbuterol, a beta-2 adrenergic agonist has recently been shown to partially reverse cardiac remodeling by inducing physiological hypertrophy. Furthermore, thyroid hormone, a well establish molecule of inducing physiological hypertrophy has been shown to reverse cardial remodeling. The present study further investigated potential underlying mechanisms of this effect in a neonatal cardiomyocytes cell based model. Neonatal cardiomyocytes obtained from newborn rats were exposed to clenbuterol (CLEN, 1κΜ) and T(3) (T3, 100nM) for 8 min, 60 min and 5 days, while untreated cells served as controls. CLEN administration resulted in well organized and orientation of cytoskeletal fibers manifesting as a longitudinal cell shape, while had no effect on myosin heavy chain (MHC) isoform expression. This response was accompanied by a 2.2 fold increase in phospho-p38 MAPK levels at 5 days and a 2.8 fold increase in phospho-JNK levels at 8 min as compared to untreated cells, p<0.05 while no changes were observed in ERK and Akt. The levels of TRs expression were no significantly changed. Administration of SB203580 (a specific p38 MAPK inhibitor) abrogated the CLEN induced changes in cardiomyocyte morphology, while it had no effect on TRs and myosin heavy chain (MHC) isoform expression. T(3) administration resulted in an elongated cell shape and well oriented and organized cytoskeletal fibers, while α-MHC isoform expression was, significantly, increased, p<0.05 and β-MHC isoform expression was, significantly, reduced p<0.05. This response was accompanied by a 1.9-fold increase in phosphoERK levels early at 8 min which, within 60 min, returned to the levels of the untreated cells. Phospho-JNK levels were 2.0 fold significantly reduced within 60 min after T(3) treatment while no changes in the expression of phospho-Akt and phospho-p38 MAPK were found between the T(3) treated and untreated cells. This response was accompanied by a 2.5-fold increase in TRα1, p<0.05 and no changes in TRβ1 levels were observed. In conclusion, clenbuterol induces favorable changes in neonatal cardiomyocyte shape and geometry without affecting MHC isoform expression. Activation of p38 MAPK signaling seems, at least in part, to be implicated in this response. T(3), also, induces changes in cardiomyocyte shape and geometry with a significant reduction in β-MHC and an increase in α-MHC isoform expression. This response involves the ERK kinase signaling.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Spanou, Danai
- Σπανού, Δανάη
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27902